TransMedics Group, Inc. TMDX Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Product | |||||
| Heart Product | $126.01M+14.7% | $109.86M+50.3% | $73.09M+90.6% | $38.35M+117% | |
| Liver Product | $460.53M+48.7% | $309.62M+104% | $151.82M+228% | $46.26M+2,316% | |
| Lung Product | $14.86M-15.9% | $17.68M+49.6% | $11.82M+33.6% | $8.85M-17.0% | |
| Cost Of Revenue by Product | |||||
| Product | $77.82M+33.4% | $58.35M+42.3% | $41.02M+142% | $16.97M+87.9% | |
| Service | $164.87M+36.1% | $121.11M+160% | $46.52M+315% | $11.22M+15,479% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does TransMedics Group, Inc. break its business down?
- TransMedics Group, Inc. (TMDX) reports revenue by product across 3 parts — Heart Product, Liver Product and Lung Product. Each is extracted from the segment footnotes and tracked over time.
- Where does TransMedics Group, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in TransMedics Group, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
